Stem Cell Therapies Course for Parkinson’s Disease Clinicians

Key Summary

• The International Society for Stem Cell Research launched a new continuing education course on stem cell therapies for Parkinson’s disease.
• The program is jointly provided by Harvard Medical School.
• Designed for clinicians, nurses, and researchers, it explains the science behind dopamine neuron replacement and current clinical trials.
• Participants can earn 2.0 AMA PRA Category 1 Credits™ and 2.0 ANCC contact hours.
• The course aims to help healthcare professionals distinguish rigorous clinical research from unproven stem cell interventions marketed to patients.

Stem Cell Therapies for Parkinson’s Disease Course Launched by ISSCR

Stem cell therapies for Parkinson’s disease are drawing growing attention in both neurology and regenerative medicine. To help clinicians better understand the scientific evidence behind these therapies, the International Society for Stem Cell Research has introduced a new continuing education program titled “Stem Cell Medicine: Parkinson’s Disease.”

The course, jointly provided with Harvard Medical School, gives healthcare professionals an evidence-based overview of how stem cell research is progressing toward clinical application for Parkinson’s disease.

Developed primarily for neurologists, nurses, researchers, and other healthcare professionals, the program examines emerging regenerative treatment strategies and highlights ongoing clinical trials exploring dopamine neuron replacement. 

It aims to help clinicians understand how laboratory research is translating into potential therapeutic approaches for Parkinson’s disease.

Why Clinicians Need Education on Stem Cell Therapies for Parkinson’s Disease

Interest in experimental therapies among people living with Parkinson’s disease continues to rise. As a result, clinicians are increasingly asked about the safety, effectiveness, and availability of stem cell–based treatments.

This new course addresses these concerns by presenting key scientific and clinical concepts in a structured format. Topics covered include:

• The biological basis for dopamine neuron replacement
• Current stem cell clinical trials for Parkinson’s disease
• Comparisons between regenerative therapies and existing treatment approaches
• Ethical and regulatory considerations surrounding stem cell medicine

According to Jaime Imitola, the program helps clinicians evaluate emerging research while providing patients with clear, science-based guidance. 

It also supports healthcare professionals in distinguishing validated clinical research from unproven stem cell interventions, which remain a challenge within regenerative medicine.

Expert Faculty and Patient Perspectives Highlight Clinical Research

The course features insights from leading clinicians and researchers working in regenerative neurology. Faculty contributors include:

• Roger Barker, whose research focuses on translating stem cell therapies for neurodegenerative diseases into clinical practice.
• Claire Henchcliffe of the University of California, Irvine, a recognized expert in clinical trials investigating regenerative treatments for Parkinson’s disease.

The program also includes a patient perspective from Andrew Cassy, who shares his experience of receiving a stem cell-derived neuron transplant as part of ongoing research.

ISSCR Chief Executive Officer Keith Alm noted that the initiative reflects the organization’s commitment to ensuring physicians have access to reliable, science-based education as stem cell therapies move closer to real-world clinical use.

Course Access, Credits, and Global Availability

The continuing education course is open to clinicians, nurses, researchers, patients, and patient advocates interested in regenerative medicine.

Key details:

• Free learning pathway: Access to educational content
• Paid pathway: Certificate of completion and continuing education credit
• Credits available: Up to 2.0 AMA PRA Category 1 Credits™ and 2.0 ANCC contact hours
• Language availability: Six languages

The program was developed by the ISSCR Education Committee and supported by educational grants from Bayer AG, BlueRock Therapeutics, and Novo Nordisk.

Along with that, Explore All Neurology CME Conferences & Free Online Courses

By offering clinically focused education, the course helps healthcare professionals better understand the scientific progress and clinical realities of stem cell therapies for Parkinson’s disease, supporting informed patient care decisions in a rapidly developing field.

Source:

International Society for Stem Cell Research